AXON Communications

AXON, a global healthcare consulting firm, harnesses the diverse expertise of our talented team to help our clients create science-based strategies and drive stakeholder activation.  

AXON serves the healthcare communications needs of clients in the pharmaceutical, medical devices and health services areas, from offices in the UK, Denmark, US and Canada. The team includes experienced consultants who have worked in agencies and in-house roles, both internationally and locally. 

Our diverse backgrounds include public relations, scientific communications, CME, journalism, advocacy/NGOs, clinical development, pharma sales and marketing, and corporate communications. It is this unrivalled combination of skills that enables us to provide novel perspectives to our clients and work with them to develop truly innovative approaches to communications.     

Contact details

Parkshot House
5 Kew Road
Richmond
Surrey
TW9 2PR
Phone number: +44 (0)20 3595 2400
Web address: http://www.axon-com.com
Email address: info-ldn@axon-com.com

Company details

Date established: 2003
Number of local staff: 34
Expertise:

AXON Communications is a truly integrated agency offering specialist consultancy across areas of our expertise, including:

  • Public relations, advocacy,  corporate and policy communications, issues management, media relations
  • Medical communications, medical writing, opinion leader programmes, CME, marketing materials, congress activities
  • Clinical trial support services, clinical trial recruitment and retention, investigator communications
  • Market access, stakeholder  mapping and engagement, communications strategy and issues management
  • Emerging markets, campaign  development, professional education, branding

 

Additional services:

AXON's team of experienced consultants includes specialists in public relations, medical education, market access, clinical trial support services, corporate reputation and issues management. 

We bring expertise and insights to clients running programmes that are global, pan-European, US, UK and in emerging markets.

Latest content